10-Q: KindlyMD's Bitcoin Pivot Drives Massive Loss Amid Revenue Drop

Sentiment:

Quarterly Report


KindlyMD reports a significant net loss and revenue decline in Q3 2025, driven by its strategic shift to Bitcoin treasury operations and the acquisition of Nakamoto Holdings.

Delay expectedThe Loan Agreement with Antalpha Digital Pte. Ltd. had an initial maturity date of November 6, 2025, which Naka elected to extend for an additional 30 days, now maturing on December 6, 2025.
Capital raiseThe company completed PIPE Financings totaling approximately $540 million through the issuance of common stock and pre-funded warrants.Entered into a Sales Agreement for an At-The-Market (ATM) Offering, allowing the sale of up to $5 billion in common stock, with $5,659,975 net proceeds raised in Q3 2025.Secured a $203,017,500 Naka SPV2 Credit Facility and a $206,000,000 USDT Master Loan Agreement (subsequent event).The company explicitly states its strategy involves "issuing debt or equity securities or engaging in other capital raising transactions with the objective of using the proceeds to purchase additional Bitcoin."
Worse than expectedNet loss for Q3 2025 increased significantly to $86,035,808 from $1,014,147 in Q3 2024.Net loss for the nine months ended September 30, 2025, increased to $89,487,606 from $2,616,126 in the prior year.Revenue decreased by 40.1% in Q3 2025 and 35.0% for the nine months ended September 30, 2025.Operating expenses increased by 535.8% in Q3 2025 and 242.7% for the nine months ended September 30, 2025.Incurred significant realized and unrealized losses on digital assets totaling over $23 million for the nine months ended September 30, 2025.Recognized a substantial loss of $59,753,811 on the acquisition of Nakamoto Holdings, Inc.Reported a working capital deficit of $187,407,725 as of September 30, 2025.Identified a material weakness in internal controls over financial reporting and ineffective disclosure controls.

Summary

  • KindlyMD reported a net loss of $86,035,808 for the three months ended September 30, 2025, a substantial increase from a net loss of $1,014,147 in the prior year period.
  • For the nine months ended September 30, 2025, the net loss was $89,487,606, compared to $2,616,126 for the same period in 2024.
  • Revenue decreased by 40.1% to $388,209 for the three months ended September 30, 2025, and by 35.0% to $1,376,391 for the nine months, primarily due to lower cash-pay patient care services and the closure of a Utah location.
  • Operating expenses surged by 535.8% to $10,793,731 for the three months and by 242.7% to $15,215,145 for the nine months, largely due to increased salaries, wages, and general and administrative costs related to the Nakamoto merger and leadership expansion.
  • The company completed the acquisition of Nakamoto Holdings, Inc. on August 14, 2025, issuing 22,321,143 shares of common stock valued at $24,999,679.
  • A loss of $59,753,811 was recognized on the acquisition of Nakamoto, measured as the difference between consideration paid and net identifiable assets/liabilities.
  • KindlyMD adopted a Bitcoin treasury and investment strategy, acquiring 5,765 Bitcoin for approximately $681 million, holding 5,398 Bitcoin with a fair value of $615,798,837 as of September 30, 2025.
  • The company recognized an unrealized loss of $22,066,010 on digital assets for the three months and $22,105,029 for the nine months ended September 30, 2025.
  • Substantial capital was raised through PIPE Financings totaling approximately $540.4 million and an At-The-Market Offering, which generated $5,659,975 during the quarter.
  • A $200.0 million Secured Convertible Debenture was fully repaid, resulting in a $14,454,485 loss on extinguishment of debt.
  • The company entered into a $206,000,000 USDT Master Loan Agreement with Antalpha Digital Pte. Ltd. on October 6, 2025, secured by Bitcoin collateral.
  • A material weakness in internal controls over financial reporting was identified, and disclosure controls and procedures were deemed not effective as of September 30, 2025.

Sentiment

Score: 3

Explanation: The company reported a massive net loss and significantly increased operating expenses, primarily driven by the acquisition of Nakamoto Holdings and related Bitcoin treasury strategy. While substantial capital was raised, the core healthcare revenue declined, and the company faces significant risks related to Bitcoin price volatility, regulatory uncertainty, and identified material weaknesses in internal controls.

Positives

  • Cash and cash equivalents significantly increased to $24,185,083 as of September 30, 2025, from $2,273,624 at December 31, 2024.
  • Total assets grew massively to $692,421,574 as of September 30, 2025, from $3,677,992 at December 31, 2024, primarily due to the acquisition of digital assets.
  • Insurance reimbursements for patient care services increased by 234.6% for the three months and 189.3% for the nine months ended September 30, 2025, indicating growth in insurance-based medical services.
  • The company successfully raised substantial capital through PIPE Financings (approximately $540.4 million) and an At-The-Market Offering ($5,659,975), demonstrating access to funding for its new strategy.
  • An unrealized gain on investments of $930,431 was recognized for the three and nine months ended September 30, 2025, primarily from the investment in Metaplanet Inc.
  • A gain of $21,845,000 was recognized from the change in fair value of a related-party put option liability, driven by a decrease in the fair value of common stock.

Negatives

  • Net loss dramatically increased to $86,035,808 for the three months and $89,487,606 for the nine months ended September 30, 2025, compared to significantly smaller losses in the prior year periods.
  • Total revenues decreased by 40.1% for the three months and 35.0% for the nine months ended September 30, 2025, indicating a decline in the core healthcare business.
  • Operating expenses soared by 535.8% for the three months and 242.7% for the nine months ended September 30, 2025, largely due to merger-related costs and expansion of the leadership team.
  • A significant loss of $59,753,811 was incurred on the acquisition of Nakamoto Holdings, Inc.
  • The company recognized substantial unrealized losses on digital assets of $22,066,010 for the three months and $22,105,029 for the nine months ended September 30, 2025, reflecting Bitcoin price volatility.
  • A realized loss of $1,411,204 on digital assets was recorded for the three and nine months ended September 30, 2025.
  • A loss on extinguishment of debt of $14,454,485 was recognized due to the full repayment of the Convertible Debenture.
  • The company reported a working capital deficit of $187,407,725 as of September 30, 2025.
  • Research and development expenses decreased by 100.0% for the nine months ended September 30, 2025, due to the discontinuation of the enterprise data management project, resulting in a $622,008 loss on disposal of assets.

Risks

  • Bitcoin is a highly volatile asset, and its price fluctuations are likely to significantly influence financial results and the market price of listed securities.
  • The vast majority of assets are concentrated in Bitcoin holdings, limiting risk mitigation through diversification.
  • The ability to achieve the objectives of the Bitcoin strategy depends significantly on obtaining future equity and debt financing, which may not be on favorable terms or at all.
  • The Bitcoin strategy has not been tested over an extended period or under various market conditions, and its success is uncertain.
  • Exposure to counterparty risks with third-party exchanges and custodians, including potential loss of Bitcoin in case of custodian insolvency.
  • The broader digital assets industry is subject to counterparty risks, high-profile bankruptcies, and regulatory enforcement actions, which could adversely impact Bitcoin adoption and price.
  • Enhanced regulatory oversight due to Bitcoin holdings, with a potential risk of classification as an investment company under the Investment Company Act of 1940.
  • Risk of security breaches or cyberattacks on information technology systems or those of third parties, potentially leading to loss of Bitcoin or sensitive data.
  • The emergence or growth of other digital assets (e.g., stablecoins, CBDCs, proof-of-stake cryptocurrencies) could negatively impact the price of Bitcoin.
  • Bitcoin holdings are less liquid than cash and cash equivalents and may not serve as a reliable source of liquidity during market instability.
  • Significant indebtedness, including the $206 million Master Loan Agreement, may impair the ability to raise further capital or service debt, and requires maintaining a specific loan-to-value ratio with Bitcoin collateral.
  • The subsidiary Naka SPV2, LLC, which holds Bitcoin, has no independent operations and depends on cash contributions or Bitcoin sales to meet its obligations.
  • Senior management has limited experience managing and operating a U.S. public company, potentially diverting attention and increasing operating costs.
  • Dependence on the services of David Bailey, CEO and Chairman, who also leads other business ventures, may create conflicts of interest.
  • Social media activity by directors and executive officers may pose risks to the company's reputation, create regulatory concerns, and impact stock price.
  • Identified material weaknesses in internal control over financial reporting could lead to material misstatements or failure to meet periodic reporting obligations.
  • Future equity offerings and warrant exercises will result in dilution to existing stockholders.
  • The market price of common stock may be volatile and affected by factors different from those that historically impacted the company prior to the Bitcoin strategy shift.
  • Potential exposure to the 15% corporate alternative minimum tax (CAMT) under the Inflation Reduction Act of 2022 due to unrealized gains on Bitcoin holdings.
  • Risks associated with integrating acquired businesses and assets, and the potential failure to realize anticipated benefits and synergies from the Nakamoto merger and future acquisitions.
  • Litigation related to mergers, acquisitions, or other strategic transactions could result in significant costs, delays, or adverse impacts.

Future Outlook

The company expects continued growth in insurance-based reimbursements for its healthcare services. It intends to fund further Bitcoin acquisitions primarily through issuances of common stock and various fixed-income instruments, viewing Bitcoin holdings as long-term. The company will continually examine the risks and rewards of its Bitcoin strategy and may expand operations beyond the legacy medical business and Bitcoin treasury strategy to include other income streams. It also anticipates needing to raise additional capital through borrowings or equity issuances to cover short-term liquidity needs, including the upcoming maturity of its $206 million Master Loan Agreement and additional Bitcoin security requirements.

Management Comments

  • "Based on improvements in referral rates due to increased payor access, we expect the growth of insurance-based reimbursements to continue into the next fiscal year."
  • "Our Company believes these methods [integrated approach to health care services combined with data utilization] to be superior in managing the root cause of symptoms and improving health outcomes faster."
  • "We view our Bitcoin holdings as long-term holdings and expect to continue to accumulate Bitcoin in the future."
  • "We have not set any specific target for the amount of Bitcoin we seek to hold and will continue to monitor market conditions in determining whether to engage in additional financings to purchase additional Bitcoin."
  • "We expect that our cash and cash equivalents and our revenues generated from our current operations will not be sufficient to cover our needs over the next twelve months; we expect to meet remaining needs through borrowings under existing or new financing arrangements, issuances of equity, and selective Bitcoin sales."
  • "We continue to work with potential lenders, including Holder, to refinance the existing Loan and have engaged an advisory investment banking firm to assist us with this effort."

Industry Context

KindlyMD's strategic pivot into Bitcoin treasury operations aligns with a growing trend of public companies exploring digital assets as a reserve asset, notably pioneered by companies like MicroStrategy. This move positions KindlyMD within the nascent but rapidly evolving Bitcoin ecosystem, seeking to leverage network effects and expand corporate Bitcoin holdings globally. However, this shift also exposes the company to the extreme volatility and regulatory uncertainties inherent in the digital asset market, which has recently seen high-profile bankruptcies and increased scrutiny. The emergence of spot Bitcoin and Ether ETPs provides traditional investors with alternative, potentially less risky, avenues for digital asset exposure, which could impact the perceived value proposition of KindlyMD's common stock as a Bitcoin proxy. Meanwhile, its legacy healthcare business is shifting towards insurance-based models, reflecting broader trends in value-based care, but faces revenue declines in cash-pay services.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Investment OfficerNATyler Evans2025-08-14New employment agreement in connection with the Nakamoto merger and strategic shift.
Chief Commercial OfficerNAAndrew Creighton2025-08-14New employment agreement in connection with the Nakamoto merger and strategic shift.
ExecutiveNATim Pickett2025-08-14Addendum to Executive Employment Agreement in connection with the Nakamoto merger.
ExecutiveNAJared Barrera2025-08-14Addendum to Executive Employment Agreement in connection with the Nakamoto merger.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorized Shares IncreaseThe authorized shares of Common Stock were increased to 10,000,000,000 from 100,000,000.2025-08-11Enables significant future equity issuances for capital raising and acquisitions, potentially leading to substantial dilution for existing shareholders.
Internal Control WeaknessIdentified a material weakness in internal controls over financial reporting related to segregation of duties, insufficient accounting resources, lack of formalized risk assessment, and inadequate documentation of policies and procedures.2025-09-30Indicates a risk of material misstatements in financial statements and potential failure to meet periodic reporting obligations, which could diminish investor confidence and negatively impact stock price. Management is focused on remediation.

Legal Proceedings

  • The company is a party to various lawsuits, claims, and other legal proceedings arising in the ordinary course of business, including commercial disputes, intellectual property matters, and employment-related matters.
  • Management believes none of the pending lawsuits, claims, and other proceedings are expected to have a material adverse effect on the company's business, financial position, results of operations, or cash flows, but acknowledges that judgment may prove inaccurate.

Related Party Transactions

  • The company assumed a Marketing and Sales Agreement (BTC Media Agreement) from Nakamoto with BTC Inc., which includes put and call options for BTC Inc. equity interests. BTC Inc. is considered a related party as David Bailey (CEO & Chairman) and Tyler Evans (CIO) hold director/officer positions at BTC Inc.
  • A put option liability-related party of $5,469,000 was recognized as of September 30, 2025, with a $21,845,000 gain from the change in fair value during the quarter.
  • The company entered into an Administrative Services Agreement with BTC Inc. on August 14, 2025, for administrative support services.
  • David Bailey, CEO and Chairman, and Tyler Evans, CIO, have significant influence over BTC Inc. and UTXO, which may create conflicts of interest with KindlyMD's interests.

Stakeholder Impact

  • **Shareholders**: Experience significant dilution from recent and future equity issuances. Face substantial risks from Bitcoin price volatility, regulatory uncertainty, and the company's untested new strategy. The stock price is likely to remain volatile. The material weakness in internal controls could erode confidence.
  • **Employees**: Increased salaries and wages due to merger-related employment and consulting agreements, and expansion of the leadership team. Potential for changes in roles and responsibilities due to the strategic shift.
  • **Customers (Healthcare)**: The company is shifting towards insurance-billed medical services, which may impact cash-pay patients. Closure of a Utah location may affect access for some patients.
  • **Creditors**: The company has incurred significant indebtedness, including a $206 million loan secured by Bitcoin collateral, exposing creditors to Bitcoin price risk and the company's ability to refinance or service debt. The working capital deficit indicates short-term liquidity challenges.
  • **Suppliers**: No specific impact mentioned, but general operational changes and financial performance could indirectly affect supplier relationships.

Next Steps

  • Continue to implement the Bitcoin treasury strategy, including acquiring additional Bitcoin through debt or equity issuances.
  • Monitor market conditions to determine further Bitcoin acquisitions and potential financings.
  • Work with potential lenders to refinance the existing $206 million Master Loan Agreement with Antalpha Digital Pte. Ltd. by its extended maturity date of December 6, 2025.
  • Address and remediate the identified material weaknesses in internal controls over financial reporting.
  • Hold the 2025 Annual Meeting of Stockholders on December 17, 2025.
  • Evaluate and pursue potential mergers, acquisitions, investments, joint ventures, and other strategic transactions to expand the Bitcoin ecosystem and services.

Key Dates

DateDescription
2024-01-10SEC approved the listing and trading of spot Bitcoin ETPs.
2024-01-11Approved spot Bitcoin ETPs commenced trading directly to the public.
2024-04Most recent Bitcoin block reward halving event occurred.
2024-05-23SEC approved rule changes permitting the listing and trading of spot ETPs that invest in ether.
2024-07-23Approved spot ETPs for ether commenced trading directly to the public.
2024-12-15ASU 2023-08 (Crypto Assets) is effective for annual periods beginning after this date.
2025-01-01Company adopted ASU 2023-08 (Crypto Assets).
2025-05-12Company entered into the Agreement and Plan of Merger with Nakamoto Holdings, Inc. and the Secured Convertible Debenture Purchase Agreement.
2025-05-20Board of directors and stockholders approved the Second Amended and Restated Articles of Incorporation.
2025-06-19Company entered into additional subscription agreements for the Additional PIPE Financing.
2025-08-11Second Amended and Restated Articles of Incorporation became effective upon filing with the Utah Division of Corporations.
2025-08-14Closing Date of the merger with Nakamoto Holdings, Inc.; Company issued 22,321,142 shares of Common Stock to Nakamoto shareholders; Company issued PIPE Securities; Company issued 3,000,000 Convert Fee Shares; Company entered into Administrative Services Agreement with BTC Inc.; Addendums to Executive Employment Agreements for Tim Pickett and Jared Barrera, and Employment Agreements for Tyler Evans and Andrew Creighton became effective.
2025-08-26Company entered into a Sales Agreement for an At-The-Market Offering of up to $5,000,000,000.
2025-09-04Nakamoto made an investment in Treasury B.V.
2025-09-09Nakamoto made a commitment to purchase up to $30 million of shares of common stock of Metaplanet Inc.
2025-09-11Company issued 273,038 shares of Common Stock for intangible assets.
2025-09-17Metaplanet Inc. International Offering closed.
2025-09-24Board established December 17, 2025, as the date of the 2025 Annual Meeting of Stockholders.
2025-09-29Company executed its option of redemption for the Convertible Debenture.
2025-09-30End of the fiscal quarter; Convertible Debenture was fully repaid; Company, through its subsidiary Naka SPV2, LLC, entered into a Credit Facility Agreement with Two Prime Lending Limited for $203,017,500.
2025-10-03Filing date of Current Report on Form 8-K regarding the Naka Credit Facility.
2025-10-06Naka entered into a Master Loan Agreement with Antalpha Digital Pte. Ltd. for $206,000,000 USDT, using proceeds to satisfy the Naka Credit Facility.
2025-10-07Filing date of Current Report on Form 8-K regarding the Antalpha Loan Agreement.
2025-10-23Record date for determining stockholders entitled to receive notice of and vote at the 2025 Annual Meeting.
2025-11-03Filing date of definitive proxy statement for the 2025 Annual Meeting.
2025-11-06Initial maturity date of the Master Loan Agreement with Antalpha Digital Pte. Ltd. (extended to December 6, 2025).
2025-11-14Date as of which 439,850,889 shares of common stock were issued and outstanding; also date for Bitcoin collateral and unencumbered Bitcoin figures.
2025-11-19Signing date of the 10-Q report by CEO and CFO.
2025-12-06Extended maturity date of the Master Loan Agreement with Antalpha Digital Pte. Ltd.
2025-12-15ASU 2023-09 (Income Tax Disclosures) is effective for fiscal years beginning after this date.
2025-12-17Date of the 2025 Annual Meeting of Stockholders.
2026-09-30Maturity date of the Naka Credit Facility (which remains open and available for future borrowings).
2026-12-15ASU 2024-03 (Income Statement Expense Disaggregation) is effective for annual periods beginning after this date.
2027-12-15ASU 2024-03 (Income Statement Expense Disaggregation) is effective for interim periods beginning after this date.

Recommendation

sell

The company is undergoing a highly speculative and risky strategic pivot into Bitcoin treasury operations, which has already resulted in a massive net loss of $89.5 million for the nine months ended September 30, 2025, primarily due to acquisition costs and unrealized losses on Bitcoin. While significant capital has been raised, the core healthcare business revenue is declining, and the company faces substantial and explicitly detailed risks, including extreme Bitcoin price volatility, enhanced regulatory scrutiny, significant indebtedness with Bitcoin collateral requirements, and identified material weaknesses in internal controls. The strategy is untested, and management has limited experience with U.S. public company operations. The combination of declining core business, massive losses, high operational costs, and significant exposure to a volatile, unregulated asset class, coupled with internal control deficiencies, presents an extremely high-risk profile with an unclear path to sustainable profitability. Investors should consider divesting to avoid further potential losses and exposure to these amplified risks.

Keywords

Bitcoin treasury strategy, Digital assets, Nakamoto Holdings acquisition, SEC 10-Q, Cryptocurrency investment, Financial results, Net loss, Capital raise, Debt financing, Internal controls weakness, Healthcare services, Patient care, Corporate governance, Market risk, Volatility, PIPE financing, ATM offering, Metaplanet Inc., Treasury B.V.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.